Join us at Endpoints 11 in September in Boston No images? Click here Endpoints 11 returns as biotech finds its footing Endpoints News is back in Boston this September to reveal the 2025 Endpoints 11 — the handpicked biotech startups we believe will define the industry's next chapter. Join the live unveiling at the State Room, where real conversations happen and reputations are made. Early bird rate — save $150 — limited in-person tickets George Church will join us for a featured fireside chat, bringing his signature mix of cutting-edge genomics insight and frank industry commentary. While biotech faces its toughest funding environment in years, the companies we're spotlighting have kept advancing their programs and hitting key milestones. These aren't the flashy unicorns of 2021 — they're biotechs grinding through Phase 2 trials, closing strategic partnerships, and building the kind of sustainable operations that can weather market volatility. ![]() George Church, Professor of Genetics ![]() The evening will feature fireside chats and editorial conversations — expect candid discussions about what it actually takes to succeed right now. Meet the future of biotech — join us. Save $150 with Early Bird — Limited in-person tickets |